

Individually, both companies have a track record of helping clients to optimize the selection, use, and analysis of behavioral endpoints to mitigate trial risk and increase the likelihood of a study’s success.

WCG acquired MedAvante and ProPhase in May, 2017, bringing together over 180 clinicians, scientists and technologists who specialize in the field of eCOA. “Because their outcomes rely on subjective assessment, we believe that continued innovation in signal detection is the key to unlocking new treatments in these therapeutic areas.” Deieso, PhD, Chairman and Chief Executive Officer (CEO), WCG.

“Despite the large and growing unmet medical need, clinical trials in CNS and behavioral health progress more slowly – and attract less funding – than other therapeutic areas,” said Donald A. Herne and Cioffi are tasked with expanding MedAvante-ProPhase’s already formidable portfolio of services and technologies, which improve the quality of clinical trial data collection and analysis in the fields of CNS and mental health. Princeton, NJ – Aug– WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced today that industry experts Steven Herne and Michael Cioffi have joined the leadership of MedAvante-ProPhase, the Group’s electronic clinical outcomes assessment (eCOA) arm. Industry experts will help to drive company’s growth in central nervous system (CNS) and behavioral health assessment markets Remote Assessments Continuously detect, assess, and correct vulnerabilities to primary or subjective endpoints during the COVID-19 pandemic.Remote Clinical Research Coordinators Augment site resources with remote strategies and personnel.Download Change in Research Form Click to download our Change In Research (CIR) submission form.COVID-19 and Participation in Clinical Trials Patient perspectives and resources on clinical trials and COVID-19.COVID-19 Trial Insights Data and insights on trial activity for COVID-19 treatments and vaccines.
#Medavante prophase series
